Last reviewed · How we verify
Basic treatment
Basic treatment is a Small molecule drug developed by The Third Affiliated hospital of Zhejiang Chinese Medical University. It is currently FDA-approved. Also known as: Health education and medication, immunosuppressor, health education ， basic drug therapy, Immunosuppressive drugs.
At a glance
| Generic name | Basic treatment |
|---|---|
| Also known as | Health education and medication, immunosuppressor, health education ， basic drug therapy, Immunosuppressive drugs |
| Sponsor | The Third Affiliated hospital of Zhejiang Chinese Medical University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. (NA)
- A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC) (PHASE2)
- "Improving Health and Reducing Chronic Disease Risk in Middle-Aged Adults Through Nutrition" (NA)
- Deployment and Clinical Evaluation of an AI-powered Digital Oncology Biomarker Tool to guidE Treatment in TNBC
- WEB-BASED FILIAL THERAPY IN PEDIATRIC CANCER (NA)
- Effect of Anticoagulant Therapy on Endometrial Receptivity and Pregnancy Outcomes in Infertility
- Shared Decision-Making Decision Aid for Newly Diagnosed Breast Cancer : A Multi-Center Randomized Controlled Trial (NA)
- The Effectiveness of Neurodevelopmental Treatment (Bobath) and Functional Physiotherapy in Children With Cerebral Palsy. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Basic treatment CI brief — competitive landscape report
- Basic treatment updates RSS · CI watch RSS
- The Third Affiliated hospital of Zhejiang Chinese Medical University portfolio CI
Frequently asked questions about Basic treatment
What is Basic treatment?
Basic treatment is a Small molecule drug developed by The Third Affiliated hospital of Zhejiang Chinese Medical University.
Who makes Basic treatment?
Basic treatment is developed and marketed by The Third Affiliated hospital of Zhejiang Chinese Medical University (see full The Third Affiliated hospital of Zhejiang Chinese Medical University pipeline at /company/the-third-affiliated-hospital-of-zhejiang-chinese-medical-university).
Is Basic treatment also known as anything else?
Basic treatment is also known as Health education and medication, immunosuppressor, health education ， basic drug therapy, Immunosuppressive drugs.
What development phase is Basic treatment in?
Basic treatment is FDA-approved (marketed).
Related
- Manufacturer: The Third Affiliated hospital of Zhejiang Chinese Medical University — full pipeline
- Also known as: Health education and medication, immunosuppressor, health education ， basic drug therapy, Immunosuppressive drugs
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing